UPDATE : Wednesday, January 22, 2020
상단여백
Gemvax & Kael's GV1001 shows efficacy as prostate cancer treatment by Lee Han-soo 2019-10-23 10:59
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent by Kim Yun-mi 2019-10-22 14:17
Pharma industry hits government steps regarding ranitidine ban by Lee Han-soo 2019-10-21 17:16
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’ by Jeong Sae-im 2019-10-21 16:42
GSK applies for additional indication of asthma inhaler Trelegy Ellipta by Lee Han-soo 2019-10-21 15:32
라인
Drug firms’ Q3 earnings to be fairly good by Jeong Sae-im 2019-10-21 12:27
Regulator OKs Jeil's advanced colorectal cancer treatment by Lee Han-soo 2019-10-21 11:38
Ministry OKs ATGC's p1, 2 trial for BTX by Lee Han-soo 2019-10-18 18:23
Physicians feel burdened by Ranitidine ban: survey by Lee Han-soo 2019-10-18 16:48
Daewoong launches BTX in Canada by Lee Han-soo 2019-10-18 14:31
라인
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech by Lee Han-soo 2019-10-17 17:59
US sales of Remicade drop due to biosimilar’s rise by Jeong Sae-im 2019-10-17 13:32
'Eisai's Lenvima extends survival period, improves patients’ quality of life' by Lee Han-soo 2019-10-16 18:22
‘New drug approval process takes about 300 days in Korea’ by Lee Han-soo 2019-10-16 15:06
Merck Korea forcefully shuts down general medicine biz by Kim Yun-mi 2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration by Kim Yun-mi 2019-10-15 13:56
Medytox, Daewoong still in dispute over Nabota's spore appraisal by Lee Han-soo 2019-10-15 11:28
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients by Lee Han-soo 2019-10-14 18:01
HanAll's Chinese partner ends P2 trial of dry eye treatment by Lee Han-soo 2019-10-14 14:08
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
여백
여백
여백
Back to Top